063 A new case series of Olmsted syndrome subjects confirms EGFR activation and shows remarkable efficacy of targeted systemic EGFR inhibition with acceptable side effects.
J. Basset, Y. Diab, F. Santiago, L. Azulay, K. Cordoro, A. Zhang, A. Kirkorian, F. Bradley, F. Watanabe, D. Siegel, E. Bourrat, R. Howard, A. Hovnanian
PMID: